TG THERAPEUTICS, INC. - Common Stock (TGTX)

Historical Holders from Q1 2014 to Q1 2025

Symbol: TGTX on Nasdaq
CUSIP: 88322Q108
Type / Class: Equity / Common Stock
Shares outstanding: 156M
All holders as of December 31, 2024: Q4 2024
Shares, excl. options: 96.8M
Holdings value: $2.91B
% of all portfolios: 0.005%
Grand Portfolio weight change: 0%
Number of holders: 329
Number of buys: 163
Number of sells: -151
Average Value change %: 0%
Average buys %: +0.002%
Average sells %: -0.002%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of TG THERAPEUTICS, INC. - Common Stock (TGTX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10.01%		$615M		15.6M		The Vanguard Group	Dec 31, 2024

Institutional Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	822K	$32.4M	-$4.29M			$39.43	39
2024 Q4	96.8M	$2.91B	-$69.8M	90.5M	113M	$30.10	329
2024 Q3	101M	$2.36B	-$22.9M	39.7M	54.5M	$23.39	301
2024 Q2	93.1M	$1.66B	+$72.1M	25.7M	32.4M	$17.79	250
2024 Q1	89.4M	$1.36B	-$24.6M	26.4M	39.8M	$15.21	236
2023 Q4	88.8M	$1.52B	+$83.7M	43.4M	58.2M	$17.08	227
2023 Q3	89.6M	$748M	-$269M	17.8M	15M	$8.36	228
2023 Q2	87.3M	$2.17B	-$103M	83.2M	103M	$24.84	239
2023 Q1	93.8M	$1.41B	+$45.7M	17.5M	26.4M	$15.04	204
2022 Q4	93.3M	$1.1B	-$28.4M	29.6M	45.5M	$11.83	193
2022 Q3	97.6M	$578M	-$20.7M	5.68M	26.2M	$5.92	164
2022 Q2	88.8M	$377M	+$45.4M	6.02M	17.1M	$4.25	155
2022 Q1	99.7M	$948M	-$98.4M	12.2M	19.4M	$9.51	166
2021 Q4	99.7M	$1.89B	+$31.2M	35.6M	43.8M	$19.00	181
2021 Q3	96.3M	$3.2B	-$41.7M	34.8M	44.7M	$33.28	214
2021 Q2	95.5M	$3.71B	-$96.8M	31.4M	34.7M	$38.79	228
2021 Q1	98.8M	$4.76B	-$16.9M	36.9M	26.8M	$48.20	233
2020 Q4	98.4M	$5.12B	+$668M	52.5M	77.6M	$52.02	245
2020 Q3	86.4M	$2.31B	+$117M	24.7M	30.7M	$26.76	179
2020 Q2	81.1M	$1.58B	+$377M	14.4M	25.1M	$19.48	167
2020 Q1	63.8M	$628M	+$63.3M	5.06M	30.9M	$9.84	140
2019 Q4	58.2M	$646M	+$108M	6.13M	27.3M	$11.10	131
2019 Q3	48.1M	$270M	-$15.5M	1.54M	6.38M	$5.62	106
2019 Q2	50.2M	$434M	+$22.6M	2.86M	12.3M	$8.65	113
2019 Q1	48M	$386M	+$34M	9.88M	16.2M	$8.04	105
2018 Q4	48.2M	$197M	-$2.13M	1.26M	3.47M	$4.10	106
2018 Q3	47.7M	$267M	+$32.2M	9.5M	7.54M	$5.60	120
2018 Q2	40.5M	$532M	+$24.3M	6.16M	17.8M	$13.15	120
2018 Q1	38.6M	$548M	+$48.8M	7.27M	13.8M	$14.20	118
2017 Q4	35.8M	$293M	-$8.67M	2.61M	4.21M	$8.20	101
2017 Q3	35.6M	$422M	+$16.1M	3.82M	7.61M	$11.85	95
2017 Q2	34.3M	$345M	+$34.2M	3.55M	3.14M	$10.05	102
2017 Q1	30.8M	$359M	+$141M	2.42M	5.38M	$11.65	93
2016 Q4	21.7M	$101M	-$33.4M	357K	52K	$4.65	84
2016 Q3	26.9M	$208M	-$5.61M	614K	104K	$7.74	68
2016 Q2	27.9M	$169M	-$14.6M	923K	0	$6.06	82
2016 Q1	29.6M	$252M	+$21.7M	980K	109K	$8.52	77
2015 Q4	26.9M	$321M	-$6.21M	1.1M	266K	$11.93	85
2015 Q3	24.9M	$251M	+$34.1M	374K	841K	$10.08	80
2015 Q2	23.5M	$390M	+$18.8M	2.13M	2.9M	$16.59	87
2015 Q1	18.3M	$284M	+$45.7M	1.89M	4.17M	$15.48	77
2014 Q4	15.3M	$242M	+$26.3M	1.66M	7.85M	$15.84	75
2014 Q3	15.5M	$165M	+$5.22M	797K	7.15M	$10.67	64
2014 Q2	13M	$122M	+$12.4M	775K	6.45M	$9.39	64
2014 Q1	11.6M	$80.3M	+$31.8M	142K	1.58M	$6.90	48